Interestingly, the highest positive correlation between CDC20 and KMT5A expression was seen in prostate neuroendocrine carcinoma samples (Spearman = 0.68; p < 0.0001; n = 49) (Figure 4F) [37]. This evidence concerns the gene CDC20 and prostate neuroendocrine neoplasm.